114 related articles for article (PubMed ID: 12563295)
21. Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation.
Velardi A; Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF;
Semin Immunopathol; 2008 Dec; 30(4):489-503. PubMed ID: 19002464
[TBL] [Abstract][Full Text] [Related]
22. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
Shi J; Tricot G; Szmania S; Rosen N; Garg TK; Malaviarachchi PA; Moreno A; Dupont B; Hsu KC; Baxter-Lowe LA; Cottler-Fox M; Shaughnessy JD; Barlogie B; van Rhee F
Br J Haematol; 2008 Dec; 143(5):641-53. PubMed ID: 18950462
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.
Symons HJ; Fuchs EJ
Bone Marrow Transplant; 2008 Sep; 42(6):365-77. PubMed ID: 18679375
[TBL] [Abstract][Full Text] [Related]
24. Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations.
Rajalingam R; Du Z; Meenagh A; Luo L; Kavitha VJ; Pavithra-Arulvani R; Vidhyalakshmi A; Sharma SK; Balazs I; Reed EF; Pitchappan RM; Middleton D
Immunogenetics; 2008 May; 60(5):207-17. PubMed ID: 18369612
[TBL] [Abstract][Full Text] [Related]
25. Do maternal cells trigger or perpetuate autoimmune diseases in children?
Stevens AM
Pediatr Rheumatol Online J; 2007 May; 5():9. PubMed ID: 17550578
[TBL] [Abstract][Full Text] [Related]
26. High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.
Houtchens KA; Nichols RJ; Ladner MB; Boal HE; Sollars C; Geraghty DE; Davis LM; Parham P; Trachtenberg EA
Immunogenetics; 2007 Jul; 59(7):525-37. PubMed ID: 17464504
[TBL] [Abstract][Full Text] [Related]
27. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
28. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
Masuda A; Nakamura A; Maeda T; Sakamoto Y; Takai T
J Exp Med; 2007 Apr; 204(4):907-20. PubMed ID: 17420263
[TBL] [Abstract][Full Text] [Related]
29. The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.
Chakraverty R; Sykes M
Blood; 2007 Jul; 110(1):9-17. PubMed ID: 17327406
[TBL] [Abstract][Full Text] [Related]
30. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
Miller JS; Cooley S; Parham P; Farag SS; Verneris MR; McQueen KL; Guethlein LA; Trachtenberg EA; Haagenson M; Horowitz MM; Klein JP; Weisdorf DJ
Blood; 2007 Jun; 109(11):5058-61. PubMed ID: 17317850
[TBL] [Abstract][Full Text] [Related]
31. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
[TBL] [Abstract][Full Text] [Related]
32. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
Du Z; Gjertson DW; Reed EF; Rajalingam R
Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
[TBL] [Abstract][Full Text] [Related]
33. Activation, coactivation, and costimulation of resting human natural killer cells.
Bryceson YT; March ME; Ljunggren HG; Long EO
Immunol Rev; 2006 Dec; 214():73-91. PubMed ID: 17100877
[TBL] [Abstract][Full Text] [Related]
34. Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
Frankenberger B; Regn S; Geiger C; Noessner E; Falk CS; Pohla H; Javorovic M; Silberzahn T; Wilde S; Buchner A; Siebels M; Oberneder R; Willimsky G; Pezzutto A; Blankenstein T; Schendel DJ
World J Urol; 2005 Jul; 23(3):166-74. PubMed ID: 15997395
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Hsu KC; Keever-Taylor CA; Wilton A; Pinto C; Heller G; Arkun K; O'Reilly RJ; Horowitz MM; Dupont B
Blood; 2005 Jun; 105(12):4878-84. PubMed ID: 15731175
[TBL] [Abstract][Full Text] [Related]
36. SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex.
Norman PJ; Cook MA; Carey BS; Carrington CV; Verity DH; Hameed K; Ramdath DD; Chandanayingyong D; Leppert M; Stephens HA; Vaughan RW
Immunogenetics; 2004 Jul; 56(4):225-37. PubMed ID: 15185041
[TBL] [Abstract][Full Text] [Related]
37. The pathophysiology of chronic graft-versus-host disease.
Kansu E
Int J Hematol; 2004 Apr; 79(3):209-15. PubMed ID: 15168586
[TBL] [Abstract][Full Text] [Related]
38. Alloreactive killer cells: hindrance and help for haematopoietic transplants.
Parham P; McQueen KL
Nat Rev Immunol; 2003 Feb; 3(2):108-22. PubMed ID: 12563295
[TBL] [Abstract][Full Text] [Related]
39. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
